Research map: Durability of the Humoral Response to MPXV Infection

Back to the article

Papers in this map

  1. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo · Anne W. Rimoin · 2010 · 905 citations · Cited by this paper
  2. Towards Elimination of Sexually Transmitted Infections: Research Developments and Vaccine Uptake · Jeanne Marrazzo · 2026 · Cites this paper
  3. Mpox Vaccination and Diagnosis Among Sexual and Gender Diverse Populations in Brazil: Results From a Large Nationwide Online Survey · Mayara Secco Torres Silva · 2026 · 1 citation · Related
  4. Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination · Shane Crotty · 2003 · 714 citations · Cited by this paper
  5. Using Tenofovir Diphosphate Levels to Evaluate Factors Associated With PrEP Non‐Adherence and Performance of Indirect Adherence Measures in Latin America: A Prospective, Single‐Arm, Open‐Label, Multicentre Implementation Study (ImPrEP) · Thiago S. Torres · 2026 · 1 citation · Related
  6. Clinical Course and Outcome of Human Monkeypox in Nigeria · Dimie Ogoina · 2020 · 503 citations · Cited by this paper
  7. Integrating HIV Into Sexual and Reproductive Health Services for Female Sex Workers in Buenos Aires, Argentina: A Comprehensive Model Designed Through Intersectional Collaboration · María Macarena Sandoval · 2026 · 1 citation · Related
  8. Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus · Yvette Edghill‐Smith · 2005 · 466 citations · Cited by this paper
  9. Data‐Driven, Patient‐Centred HIV Care Supports Sustained Viral Suppression: A Retrospective Programme Analysis From the Medical Research Foundation of Trinidad and Tobago · Nyla Lyons · 2026 · 1 citation · Related
  10. Diagnosis and Management of Smallpox · Joel G. Breman · 2002 · 462 citations · Cited by this paper
  11. Latin America and the Caribbean: Socioeconomic Realities and Implications for Health and HIV Responses · Claudia P. Cortés · 2026 · Related
  12. Human monkeypox – After 40 years, an unintended consequence of smallpox eradication · Karl Simpson · 2020 · 328 citations · Cited by this paper
  13. Facilitators and Barriers to Implementing Peer‐Led Neurocognitive Screening for Older Adults Living With HIV at a Community Hospital in Thailand: A Multiple‐Methods Study · 2026 · Related
  14. Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States · Nicholas P. Deputy · 2023 · 316 citations · Cited by this paper
  15. Progress and Challenges in Elimination of Vertical HIV Transmission · 2026 · Related
  16. The 2017 human monkeypox outbreak in Nigeria—Report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State, Nigeria · Dimie Ogoina · 2019 · 314 citations · Cited by this paper
  17. Correlates of Poor Quality of Life Among Older People Living With HIV: A Cross‐Sectional Analysis of the Tanzania HIV and Aging Cohort Study · 2026 · Related
  18. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals · Luca M. Zaeck · 2022 · 273 citations · Cited by this paper
  19. Timely and Efficient Infant Diagnosis Is Required to End AIDS in Children · 2026 · Related
  20. Real-world effectiveness of a single dose of mpox vaccine in males · Yael Wolff Sagy · 2023 · 207 citations · Cited by this paper
  21. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023 · Alexandra F. Dalton · 2023 · 190 citations · Cited by this paper
  22. Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination To Provide Complete Protection · Kevin L. Karem · 2007 · 177 citations · Cited by this paper
  23. Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: an observational study · Marta Bertran · 2023 · 162 citations · Cited by this paper
  24. A Prospective Study of Serum Antibody and Protection Against Smallpox · Thomas M. Mack · 1972 · 160 citations · Cited by this paper
  25. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study · Hallie Cohn · 2023 · 116 citations · Cited by this paper
  26. Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study · Chiara Agrati · 2022 · 106 citations · Cited by this paper
  27. Epidemiologic and Clinical Features of Mpox-Associated Deaths — United States, May 10, 2022–March 7, 2023 · Aspen P. Riser · 2023 · 69 citations · Cited by this paper
  28. One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines · Heiko Ilchmann · 2022 · 58 citations · Cited by this paper
  29. Case of apparent mpox reinfection · John Golden · 2023 · 52 citations · Cited by this paper
  30. Two individuals with potential monkeypox virus reinfection · Angelo Roberto Raccagni · 2023 · 48 citations · Cited by this paper
  31. Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens · Ron Yefet · 2023 · 45 citations · Cited by this paper
  32. Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study · Mario Fontán‐Vela · 2023 · 40 citations · Cited by this paper
  33. Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study · Igor Moraes-Cardoso · 2024 · 40 citations · Cited by this paper
  34. A Case of Mpox Reinfection · Stefano Musumeci · 2023 · 39 citations · Cited by this paper
  35. Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis · Nicolò Moschetta · 2023 · 37 citations · Cited by this paper
  36. Human monoclonal antibodies targeting A35 protect from death caused by mpox · Raianna F. Fantin · 2025 · 28 citations · Cited by this paper
  37. Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study · David Hillus · 2025 · 27 citations · Cited by this paper
  38. Second clinical episode of hMPX virus in a man having sex with men · Jérémy Zeggagh · 2023 · 23 citations · Cited by this paper
  39. The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response · Aaron L. Oom · 2025 · 23 citations · Cited by this paper

Source: OpenAlex (CC0)